GE HealthCare Technologies Inc. (GEHC) has initiated a research collaboration with the University of Washington Department of Radiology to enhance computed tomography (CT) and molecular imaging (MI) technologies. This partnership, announced recently, aims to automate workflows in cardiology and oncology, accelerating the transition of new imaging technologies into clinical practice.
The collaboration will focus on two main programs: one dedicated to advancing CT imaging science through research and education, and another aimed at improving personalized cancer treatment by integrating advanced diagnostic imaging and AI-driven solutions. As of now, GEHC has a market capitalization of $29.22 billion, but shares have declined by 21.7% year-to-date, compared to a 22.2% decline in the broader industry.
According to Mordor Intelligence, the U.S. diagnostic imaging market is projected to reach $10.57 billion by 2026, growing at a CAGR of 4.5% through 2031, driven by advancements in AI and portable imaging technologies.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
